Ukraine tested VR therapy in war and the results are in

More than a thousand patients in war-torn Ukraine completed nearly nine thousand sessions of mixed reality therapy across 47 organizations over six months, a new study released May 26 shows, providing the most detailed real-world evidence yet that immersive headset-based mental health tools can function at scale inside an active conflict zone’s care infrastructure.

The study, conducted in partnership with GIZ, the German development agency, examined the deployment of Aspichi’s Luminify program across hospitals, veteran support centers, psychosocial programs, and mobile care teams operating under sustained wartime pressure.

The numbers behind the study are worth holding for a moment. One hundred sixty-two headsets, 47 organizations, 1,114 patients, 8,884 completed sessions over six months: those figures describe not a clinical trial in a controlled environment but an operational deployment inside a country where air raid sirens interrupt daily life, where hospitals treat both civilian trauma and combat wounds, and where the psychological burden on the population has been accumulating since February 2022. The fact that practitioners embedded Luminify into functional care pathways under those conditions, rather than piloting it in a research setting, is what gives the study its unusual weight.

Luminify is a structured mixed reality support program that delivers guided scenarios through a headset, drawing on evidence-based therapeutic approaches including cognitive behavioral therapy, mindfulness, acceptance and commitment therapy, grounding exercises, breathing techniques, and trauma-informed design principles. Each session is structured, time-bound, and user-controlled, which means the patient can engage at their own pace while a clinician maintains oversight of the broader care pathway. The program is not designed to replace psychotherapy but to function as a stabilization tool within it, helping patients regulate emotional responses, reduce stress, improve focus, and become more ready to engage in further professional support.

That last function, preparing patients for deeper care rather than substituting for it, proved particularly significant in the Ukrainian deployment. Practitioners at veteran centers and psychosocial programs described Luminify as a lower-barrier entry point for individuals reluctant to seek traditional talk-based psychological support, a group that includes a significant proportion of both veterans and civilians in conflict-affected populations where mental health stigma and distrust of formal services remain persistent obstacles to care.

A participating psychologist at a Ukrainian resilience center described what that looked like in practice:”One of the most important effects we saw was that the headset helped people take the first step into support. Clients would hear about it from others and come in saying, ‘I came for the glasses.’ From there, the consultation could begin. In that sense, the tool helped reduce stigma and opened the door to care.”

The scale of the psychological health crisis that context sits within is difficult to overstate. The World Health Organization estimates that nearly all people affected by emergencies experience some form of psychological distress, and that one in five people exposed to war or conflict in the previous decade develops a more serious condition requiring structured support. Ukraine has now been in active armed conflict for more than four years, with the full-scale invasion beginning in February 2022 following eight years of lower-intensity conflict in the Donbas region. The mental health infrastructure serving that population was not designed to handle demand at anything approaching current scale, and the gap between need and available professional capacity has been a defining feature of the humanitarian response since the beginning.

Viktor Samoilenko, CEO and co-founder of Aspichi, described the fundamental problem the program is designed to address: “Health and recovery systems need new ways to deliver structured support without placing even more pressure on already overstretched professionals. This study shows that immersive tools can play a serious practical role: helping care teams make support more accessible, repeatable, and easier for people to engage with.”

The study’s findings also document where the limitations lie, and the candor of that documentation strengthens rather than weakens the overall assessment. Adoption varied considerably across organizations depending on differences in infrastructure quality, clinician confidence in using the technology, leadership support within individual institutions, and how well the program was integrated into existing workflow. The researchers concluded that sustainable scaling depends on clinician training, supervision protocols, care pathway integration, and standardized outcome tracking, not simply on distributing headsets. That conclusion matters because it sets a realistic standard for what responsible deployment actually requires, as opposed to the more common pattern of technology companies claiming universal applicability for tools that perform well in optimal conditions and poorly in everything else.

Aspichi’s broader deployment data, reported by the company, shows Luminify reaching more than one million users across more than six million sessions, with the Ukrainian clinic network growing from five sites in 2023 to 131 in 2025. The program has been developed in close collaboration with the Ukrainian armed forces, incorporating direct feedback from practitioners working in field conditions, and earlier research involving Ukrainian veterans with stress-related symptoms, published in PubMed, showed immersive technology-assisted therapy reducing anxiety and depression alongside reported improvements in mood, concentration, and stress resilience.

The program’s trajectory beyond Ukraine took a concrete step forward when Aspichi was selected for the PwC Scale Program: Medical Resilience for Civil and Military Use, joining 20 companies drawn from innovators across Europe and NATO member states. The eight-week program with PwC Belgium will focus on how Luminify can scale across healthcare, rehabilitation, and defense-related environments, with Aspichi scheduled to present at the program’s Innovation Day on June 24. The selection places Aspichi in a cohort that NATO-aligned defense and health institutions will be watching, at a moment when the alliance’s member governments are beginning to treat psychological resilience as a strategic capability rather than a welfare afterthought.